A retrospective observational analysis examining liquid biopsies with tissue biopsies in patients with advanced non-small cell lung cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Annual ...
Galit Meshulam-Simon is the associate director of Commercial Applications at Elegen. COVID-19 brought messenger RNA (mRNA) into the global spotlight, demonstrating its speed, flexibility, and efficacy ...
Machine Learning Model for Predicting Severe Adverse Events in Oncology Patients Using the US Food and Drug Administration Adverse Event Reporting System We developed an 8-year, monthly cycle Markov ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results